(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Omni Shoreham Hotel

Sep 23, 2009 8:00 AM - Sep 24, 2009 2:05 PM

2500 Calvert Street NW, , Washington, DC 20008 , USA

Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications: Current State of the Art and Opportunities to Advance the Science

Featured

Want to learn more about Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications: Current State of the Art and Opportunities to Advance the Science? You've come to the right site!

Continuing Education

Learn more

Program Committee

  • Philip T. Sager, MD
    Philip T. Sager, MD Adjunct Professor
    Stanford University, United States
  • Boaz Mendzelevski, MD
    Boaz Mendzelevski, MD Consultant Cardiologist
    Cardiac Safety Consultants Ltd., United Kingdom
  • Börje C. Darpö, MD, PhD
    Börje C. Darpö, MD, PhD Chief Scientific Officer, Cardiac Safety
    Clario, Sweden
  • Mary Parks, MD
    Mary Parks, MD Director, Div. of Endocrinology and Metabolism Prod., ODE II, CDER
    FDA, United States
  • Norman Stockbridge, MD, PhD
    Norman Stockbridge, MD, PhD Director, Division of Cardiology and Nephrology, OND, CDER
    FDA, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.